The degree to which novel value elements such as insurance value impact estimated treatment value for rare, severe genetic diseases such as Duchenne muscular dystrophy is unclear. Objectives: To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback